Description
Galvus 50 mg tablet (Vildagliptin) manufactured by Novartis is indicated in the treatment of type 2 diabetes (non-insulin-dependent diabetes). It belongs to a group of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Manufacturer: Novartis